- A Telegraph column offers an optimistic view regarding the future of 3D human-tissue printing, even going as far as to wonder if it will "soon be possible to 3D print a human body."
- The author notes Organovo's (ONVO +5.3%) partnership with U.K. startup PrinterInks to create a visual guide on the subject of 3D tissue printing, and that the company recently "bioprinted its first 3D liver tissue for testing purposes."
- Organovo shares spiked higher in response to the column, but have given back a portion of their gains.
From other sites
at CNBC.com (Dec 16, 2014)
at CNBC.com (Dec 12, 2014)
at CNBC.com (Dec 11, 2014)
at CNBC.com (Nov 18, 2014)
at CNBC.com (Oct 10, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs